ArticleJournal of cellular and molecular medicine2024

Correction to "FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway"Han XD, Yuan T, Zhang JL, et al. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway. J Cell Mol Med. 2022;26(11):3269-3280.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.